ABSI Absci Corporation
ABSI Absci Corporation
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $2.85 · VWAP $4.81 · +92.1% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
ABSI Price Structure
Loading timeframes…
Peers
Every watchlist ABSI belongs to, members best 30-day change first — ABSI highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
COVERAGE GAP — this name's print date has passed and tonight's bounded news pass did not include it. No coverage was acquired; nothing is asserted about the result. Refill on the next daily or when the name earns a targeted pull.
full note →Against street estimates
How ABSI's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about ABSI from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 40 days ago · Jul 9
- Absci (ABSI) Valuation in Focus After Strategic Pivot to ABS-201 and New Earnings Update
- Absci Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
- Earnings Flash (ABSI) Absci Corporation Reports Q1 Revenue $200,000
- Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript
- Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ABSI research tape
17 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to ABSI.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries